NICHD News Releases

Research Funding News: New policy on NIH grant awards, new NICHD funding strategies
A new policy has been posted on the NIH Web site regarding NIH Fiscal Operations for the remainder of FY 2013 in light of the Consolidated and Further Continuing Appropriations Act, 2013 (P.L. 113-6), signed by President Obama on March 26, 2013, and the sequestration provisions of the Balanced Budget and Emergency Deficit Control Act.

Anti-HIV therapy appears to protect children’s hearts, NIH network study shows
For children who have had HIV-1 infection since birth, the combination drug therapies now used to treat HIV appear to protect against the heart damage seen before combination therapies were available, according to researchers in a National Institutes of Health network study.

Harnessing Research to Combat Sexually Transmitted Diseases (STDs)
STDs and sexually transmitted infections (STIs) have affected health and human relationships throughout history. For STD Awareness Month this April, the NICHD highlights some of its research efforts related to STDs and STIs.

Drug safety for children and pregnant women topic of March NICHD Director’s Podcast
Once the U.S. Food and Drug Administration approves a drug, physicians can use their best judgment to prescribe it to their patients—whether or not their patients are similar to those who took part in the clinical trials. Physicians can also prescribe drugs for diseases or conditions other than those for which they were originally tested.

Toddler ‘Functionally Cured’ of HIV Infection, NIH-Supported Investigators Report
A two-year-old child born with HIV infection and treated with antiretroviral drugs beginning in the first days of life no longer has detectable levels of virus using conventional testing despite not taking HIV medication for 10 months, according to findings presented today at the Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta.

February is International Prenatal Infection Prevention Month
The NICHD supports a number of efforts to help prevent mother-to-child transmission of HIV and other infections during pregnancy, childbirth, and breastfeeding, both in the United States and in other countries. Current NICHD-supported studies are exploring better methods of prevention and treatment of these infectious diseases.

Scientific Vision: The Next Decade
The NICHD embarked upon a collaborative process in 2011 to create a scientific Vision, identifying the most promising scientific opportunities for the Institute and its partners to pursue over the next decade. The newly published Scientific Vision statement presents the results of that process and outlines scientific goals for the coming decade.

NICHD reorganizes extramural program
​Alan Guttmacher, M.D., Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) announced a number of changes to streamline the institute’s organizational structure and accelerate the exchange of scientific ideas.

Research for a Lifetime: Commemorating the NICHD’s 50th Anniversary
On October 17, 1962, President John F. Kennedy signed into law the legislation establishing the NICHD to examine “the complex process of human development from conception to old age.” The Institute marks its golden anniversary with Research for a Lifetime, an all-day scientific colloquium to highlight the Institute’s mission, accomplishments, and future research directions.

World AIDS Day and NICHD HIV/AIDS Research
​According to the World Health Organization (WHO), more than 34 million people around the world are living with HIV, and about 10% of them are children. On World AIDS Day, the NICHD reflects on its progress and its continuing efforts to keep these children healthy, to preserve the health of HIV-positive mothers, and to prevent new cases of HIV among children and adults.

HIV treatment reduces risk of malaria recurrence in children, NIH funded study shows
​A combination of anti-HIV drugs has been found to also reduce the risk of recurrent malaria by nearly half among HIV-positive children, according to researchers supported by the National Institutes of Health.

20 percent of youth with HIV didn’t know they were infected at first sexual experience
​Roughly 20 percent of youth who have had HIV since birth did not know their HIV status when they first became sexually active, according to a study by a National Institutes of Health-supported research network.

HPV vaccine may benefit HIV-infected women
​Women with HIV may benefit from a vaccine for human papillomavirus (HPV), despite having already been exposed to HPV, a study finds. Although many may have been exposed to less serious forms of HPV, more than 45 percent of sexually active young women who have acquired HIV appear never to have been exposed to the most common high-risk forms of HPV, according to the study from a National Institutes of Health research network.

NICHD's Mofenson Recognized as Federal Employee of the Year
​Lynne Mofenson, M.D., Chief of the Pediatric, Adolescent and Maternal AIDS Branch, received the Federal Employee of the Year Award from the Partnership for Public Service. The award is one of nine Samuel J. Heyman Service to America Medals bestowed on public servants who make "high-impact contributions to the health, safety and well-being of Americans."

Research on Breastfeeding & Breast Milk at the NICHD
​​Breastfeeding offers benefits to both mothers and babies. Not only does human milk provide essential calories, vitamins, minerals, and other bioactive components for optimal growth, health, and development, but the process of breastfeeding also helps mother-infant bonding. To mark World Breastfeeding Week, the NICHD describes some of its current research and research findings on breastfeeding and breast milk.

NICHD's Ongoing Research on HIV/AIDS
​​The NICHD joined the international community at AIDS 2012, a gathering of more than 20,000 leading HIV/AIDS researchers, public health experts, policy makers, individuals and members of communities affected by HIV/AIDS, and media representatives. A number of NICHD scientists participated in this important event. This spotlight highlights some recent NICHD-funded findings on HIV/AIDS.

July NICHD Director's Podcast Now Online
​The July 2012 NICHD Research Perspectives, the NICHD’s monthly podcast, is now online. This month’s podcast features research sponsored by the NICHD’s Pediatric, Adolescent and Maternal AIDS Branch. This month’s guests, Branch Chief Dr. Lynne Mofenson and Dr. Bill Kapogiannis, reported on findings to reduce the occurrence of mother-to-child transmission of HIV, the safety of one of the new anti HIV drugs, tenofovir, during pregnancy, and the risk of bone loss among young men newly diagnosed with HIV.

Adding Nevirapine to HIV Regimen Halves Newborn Transmission Rate
Adding the drug nevirapine to the regimen given to newborns of women diagnosed with HIV shortly before or during labor halves the newborns' risk of contracting the virus, according to findings by a National Institutes of Health research network.

Children Exposed to HIV in the Womb at Increased Risk for Hearing Loss
Children exposed to HIV in the womb may be more likely to experience hearing loss by age 16 than are their unexposed peers, according to scientists in a National Institutes of Health research network.

NIH Study Finds HIV-Positive Young Men at Risk of Low Bone Mass
Young men being treated for HIV are more likely to experience low bone mass than are other men their age, according to results from a research network supported by the National Institutes of Health. The findings indicate that physicians who care for these patients should monitor them regularly for signs of bone thinning, which could foretell a risk for fractures. The young men in the study did not have HIV at birth and had been diagnosed with HIV an average of two years earlier.